| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |